Commitment to Action

Developing New Tools to Fight Tuberculosis

Commitment by

Bill & Melinda Gates Foundation

In 2007, The Bill and Melinda Gates Foundation committed to provide $280,000,000 over five years to help fight tuberculosis by speeding up research and development on promising vaccines, diagnostic tests, and treatments to help reduce the global TB burden. Supported by funding from the Bill and Melinda Gates Foundation, FIND and Cepheid have developed GeneXpert, the first new TB diagnosis in over a century. GeneXpert uses DNA technology to diagnose TB. It is more effective in detecting TB in people with HIV/AIDS and can immediately determine the likelihood of drug resistance with minimal training.

Share

Tabs

Overview
Summary

Commitment

Developing New Tools to Fight Tuberculosis

Launched

2007

Est. Duration

5 Years

Estimated Total Value

$280,000,000

Region

Northern America

Countries

Global

Commitment by

Bill & Melinda Gates Foundation

Partner(s) of the Commitment Maker(s)

Aeras Global TB Vaccine Foundation, Foundation for Innovative New Diagnostics (FIND), Seattle Biomedical Research Institute